PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice[S]

PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice[S]

Proprotein convertase subtilisin kexin type 9 (PCSK9), the last member of the family of Proprotein Convertases related to Subtilisin and Kexin, regulates LDL-cholesterol by promoting the endosomal/lysosomal degradation of the LDL receptor (LDLR). Herein, we show that the LDLR cell surface levels dra...

Full description

Bibliographic Details
Main Authors:	Anna Roubtsova, Ann Chamberland, Jadwiga Marcinkiewicz, Rachid Essalmani, Ali Fazel, John J. Bergeron, Nabil G. Seidah, Annik Prat
Format:	Article
Language:	English
Published:	Elsevier 2015-11-01
Series:	Journal of Lipid Research
Subjects:	lipoproteins/receptors ldl/metabolism liver cholesterol estrogen
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520354821

Similar Items

Asociation of PCSK9 with Low Density Lipoproteins (LDL) in the Regulation of LDL-Cholesterol Levels
by: Sarkar, Samantha Khadija
Published: (2015)

PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke[S]
by: Estelle Rousselet, et al.
Published: (2011-07-01)

Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
by: Bingxiang Wang, et al.
Published: (2021-01-01)

LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice
by: P.J. Tacken, et al.
Published: (2000-12-01)

LDLCHOLESTEROLEXAMINATION (LDL-C) USINGHOMOGENEOUS ASSAY
by: Made DwiAmbara Putra
Published: (2013-07-01)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)

Can Carob-Fruit-Extract-Enriched Meat Improve the Lipoprotein Profile, VLDL-Oxidation, and LDL Receptor Levels Induced by an Atherogenic Diet in STZ-NAD-Diabetic Rats?
by: Adrián Macho-González, et al.
Published: (2019-02-01)

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
by: Aureli Luquero, et al.
Published: (2021-03-01)

Development of Inhibitors of Human PCSK9 as Potential Regulators of LDL-Receptor and Cholesterol
by: Alghamdi, Rasha Hassen
Published: (2014)

PCSK9 and LDL-C: The Role of Exercise
by: Jaeho Jin, et al.
Published: (2020-11-01)

Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
by: Bin Dong, et al.
Published: (2010-06-01)

The Functional Characterization of PCSK9's Binding Interactions with LDL and the LDL Receptor
by: Matyas, Angela
Published: (2020)

Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
by: C.J. Packard, et al.
Published: (2000-02-01)

The impact of Niacin on PCSK9 levels in vervet monkeys (Chlorocebus aethiops)
by: Ngqaneka, Thobile
Published: (2021)

The Inhibition Effect of Cell DNA Oxidative Damage and LDL Oxidation by Bovine Colostrums
by: Chih-Wei Chen, et al.
Published: (2016-10-01)

Tepung okra (Albelmoschus esculantus) menurunkan rasio kadar LDL terhadap HDL tikus hiperkolesterolemia
by: Ayu Febriyatna, et al.
Published: (2018-01-01)

Anticorpos contra LDL-ox e síndrome coronariana aguda Anticuerpos contra LDL-ox y síndrome coronario agudo Antibodies against OxLDL and acute coronary syndrome
by: Ana Maria Brito Medeiros, et al.
Published: (2010-07-01)

Reduced VLDL clearance in Apoe−/−Npc1−/− mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels
by: Minako Ishibashi, et al.
Published: (2010-09-01)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
by: Harshal A. Deshmukh, et al.
Published: (2012-05-01)

Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
by: Tiwari Hemant K, et al.
Published: (2011-08-01)

CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
by: Christian Abendstein Kjellmo, et al.
Published: (2018-05-01)

The relative atherogenicity of VLDL and LDL is dependent on the topographic site[S]
by: Eline Van Craeyveld, et al.
Published: (2010-06-01)

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role[S]
by: Frederick J. Raal, et al.
Published: (2016-06-01)

PCSK9: a convertase that coordinates LDL catabolism
by: Jay D. Horton, et al.
Published: (2009-01-01)

Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation[S]
by: Jason M. Meyer, et al.
Published: (2014-08-01)

Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci
by: Alessandra Bedin, et al.

The Effect of Volatile Oils and Vitamin C on the Affinity of LDL to Its Receptor: A Model for Prevention of Atherosclerosis
by: Mohammadreza Safari, et al.
Published: (2002-03-01)

Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake[S]
by: Adri M. Galvan, et al.
Published: (2019-01-01)

Influência do ω-3 sobre a lipoproteína de baixa densidade eletronegativa [LDL(-)], anticorpos LDL(-) e tamanho das partículas de LDL em indivíduos com síndrome metabólica
by: Diana Gabriela Estevez Fernandez
Published: (2015)

Influência do ω-3 sobre a lipoproteína de baixa densidade eletronegativa [LDL(-)], anticorpos LDL(-) e tamanho das partículas de LDL em indivíduos com síndrome metabólica
by: Estevez Fernandez, Diana Gabriela
Published: (2015)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo
by: Elise F. Villard, PhD, et al.
Published: (2016-10-01)

Autoimmune response to advanced glycosylation end-products of human LDL
by: Gabriel Virella, et al.
Published: (2003-03-01)

LDL-conjugated to GM1 micelles incorporating anticancer drugs to improve tumor cell uptake
by: Ariel Gustavo Garro, et al.
Published: (2021-04-01)

Correlation of PCSK9 and Serum sdLDL Levels and Other Demographic and Laboratory Indicators in Healthy Individuals
by: Reza Hosseini-Fard, et al.
Published: (2018-05-01)

Is there a link between proprotein convertase PC7 activity and human lipid homeostasis?
by: Johann Guillemot, et al.
Published: (2014-01-01)

PCSK9 is not secreted from mature differentiated intestinal cells
by: Moreau François, et al.
Published: (2021-01-01)

Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes
by: Hanna Wessel, et al.
Published: (2019-10-01)

Bovine Colostrum Whey Protein Hydrolysate Inhibits Cell DNA Damage and LDL Oxidation In Vitro
by: Shu-Hua Chiang, et al.
Published: (2017-03-01)

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin
by: Nuntakorn Thongtang, et al.
Published: (2017-07-01)

The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor
by: Jose Ruiz, et al.
Published: (2005-08-01)